Edition:
India

Aeglea Bio Therapeutics Inc (AGLE.OQ)

AGLE.OQ on NASDAQ Stock Exchange Global Market

7.87USD
20 Apr 2018
Change (% chg)

$-0.01 (-0.13%)
Prev Close
$7.88
Open
$7.99
Day's High
$7.99
Day's Low
$7.74
Volume
118,113
Avg. Vol
26,445
52-wk High
$11.11
52-wk Low
$2.81

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Buy -0.44 December 22 Apr 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 2 2 2 2
(2) OUTPERFORM 2 3 3 3
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.50 1.60 1.60 1.60

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Jun-18 3 1.23 2.18 0.00 0.00
Quarter Ending Sep-18 3 0.50 1.50 0.00 0.00
Year Ending Dec-18 3 3.29 6.00 0.00 0.33
Year Ending Dec-19 3 1.92 5.76 0.00 6.01
Earnings (per share)
Quarter Ending Jun-18 3 -0.44 -0.44 -0.44 -0.54
Quarter Ending Sep-18 3 -0.45 -0.45 -0.46 -0.54
Year Ending Dec-18 3 -1.83 -1.77 -1.93 -2.45
Year Ending Dec-19 3 -2.68 -1.80 -3.86 -2.74

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Dec-17 1.16 1.48 0.32 27.34
Quarter Ending Sep-17 1.09 1.26 0.17 15.95
Quarter Ending Jun-17 1.29 1.48 0.19 14.87
Quarter Ending Mar-17 1.68 0.98 0.70 41.66
Quarter Ending Dec-16 3.36 1.25 2.11 62.88

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Jun-18 1.23 1.23 1.25 1.14 0.00
Quarter Ending Sep-18 0.50 0.50 0.70 0.00 0.00
Year Ending Dec-18 3.29 3.29 4.02 2.37 0.33
Year Ending Dec-19 1.92 1.92 1.54 4.00 6.01

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Jun-18 0 0 0 0
Quarter Ending Sep-18 0 0 0 0
Year Ending Dec-18 0 0 0 0
Year Ending Dec-19 0 0 0 1
Earnings